Telo Genomics Corp. TELO.V
TSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -22.92% | 5.69% | 17.21% | 39.63% | 68.53% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -28.76% | -16.84% | -2.92% | 10.30% | 28.98% |
| Operating Income | 28.76% | 16.84% | 2.92% | -10.30% | -28.98% |
| Income Before Tax | 28.71% | 13.92% | 2.96% | -16.65% | -31.01% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 30.62% | 13.92% | 2.96% | -16.65% | -31.01% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 30.62% | 13.92% | 2.96% | -16.65% | -31.01% |
| EBIT | 28.76% | 16.84% | 2.92% | -10.30% | -28.98% |
| EBITDA | 32.16% | 19.56% | 2.47% | -11.45% | -30.63% |
| EPS Basic | 30.51% | 33.33% | 27.78% | 16.39% | 6.35% |
| Normalized Basic EPS | 29.73% | 33.33% | 29.41% | 18.42% | 7.50% |
| EPS Diluted | -4.29% | -1.41% | 0.00% | 16.39% | -11.11% |
| Normalized Diluted EPS | 29.73% | 33.33% | 29.41% | 18.42% | 7.50% |
| Average Basic Shares Outstanding | 0.41% | 30.81% | 34.64% | 39.62% | 40.26% |
| Average Diluted Shares Outstanding | 0.41% | 30.81% | 34.64% | 39.62% | 40.26% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |